Health
Multiple sclerosis drug may help treat COVID-19 and lead to faster recovery – Australian Times
Synairgen found that when SNG001 was given to patients with COVID-19, it stopped the development of more severe symptoms, accelerated their recovery, and allowed them to leave hospital earlier.
Nial Wheate, University of Sydney and Elise Schubert, University of Sydney
What do multiple sclerosis (MS) and the novel coronavirus have in common? Until this week, not much, but a recent clinical trial has shown a reformulation of a drug used to treat MS can potentially also be used to help patients infected with COVID-19.
Vadim Zakharishchev/Shutterstock
SNG001 is an inhaled form of a drug called interferon-beta under development by the UK pharmaceutical company Synairgen. Interferon is no…
Continue Reading